New Discoveries for Cancer Medicines
Cancer Chemical and Structural Biology
This program aims to find new ways to fight human cancers by discovering new drug targets and developing promising anti-cancer medicines.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11086182 on NIH RePORTER |
What this research studies
This program at the Sidney Kimmel Comprehensive Cancer Center brings together experts from many fields to tackle cancer. They are working to find new weaknesses in cancer cells that future medicines can target. Researchers are also creating and improving new drug candidates that could become powerful anti-cancer treatments. Ultimately, this work helps develop better ways to deliver these treatments to patients. The program has already advanced several compounds into preclinical and clinical development.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation at this stage, but future clinical trials stemming from this work would seek patients with specific types of cancer.
Not a fit: Patients not currently involved in clinical trials related to these specific drug candidates would not directly benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this work could lead to the development of new and more effective medicines for various human cancers.
How similar studies have performed: The program has a robust pipeline of over 19 novel lead compounds, with some already in clinical development, indicating prior success in similar approaches.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Berger, James M. — Johns Hopkins University
- Study coordinator: Berger, James M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.